Butterfly network announces fda clearance of its next-generation handheld ultrasound system, butterfly iq3

Burlington, mass. & new york--(business wire)---- $bfly #butterflyiq--butterfly network, inc. (“butterfly”) (nyse: bfly), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the fda clearance of its next-generation handheld point-of-care ultrasound (pocus) system, butterfly iq3. the new device is the company's third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system. butte.
BFLY Ratings Summary
BFLY Quant Ranking